| Identification | Back Directory | [Name]
5-fluoro ADB | [CAS]
1838134-16-9 | [Synonyms]
29g
5-fluoro ADB
5F-EMB-PINACA
(R)-5-fluoro ADB
(R)-5F-MDMB-PINACA
5-fluoro MDMB-PINACA
10KG;5KG;1KG;500G;100G;29G
PWEKNGSNNAKWBL-KRWDZBQOSA-N | [Molecular Formula]
C20H28FN3O3 | [MOL File]
1838134-16-9.mol | [Molecular Weight]
377.45 |
| Chemical Properties | Back Directory | [Boiling point ]
551.9±40.0 °C(Predicted) | [density ]
1.16±0.1 g/cm3(Predicted) | [solubility ]
DMF: 25 mg/ml; DMSO: 25 mg/ml; Ethanol: 25 mg/ml; Ethanol:PBS (pH 7.2) (1:4): 0.2 mg/ml | [form ]
Oil | [pka]
11.28±0.46(Predicted) | [color ]
Colourless |
| Hazard Information | Back Directory | [Description]
(R)-5-fluoro ADB (Item No. 16603) is an analytical reference standard categorized as a synthetic cannabinoid. It is the (R)-enantiomer of (S)-5-fluoro ADB . (R)-5-fluoro ADB is regulated as a Schedule I compound in the United States. This product is intended for forensic and research applications. | [Uses]
ADB-PINACA is an analog of AKB48 (aka APINACA; ), a synthetic cannabinoid recently identified in herbal products. Variations of ADB-PINACA have been synthesized including derivatives that include a fluorine atom added to the terminal carbon of the pentyl group. 5-fluoro ADB is an analog of a fluorinated ADB-PINACA derivative in which the terminal amide has been replaced with a methyl ester. The physiological and toxicological properties of this compound have not been determined. This product is intended for forensic and research applications.[Cayman Chemical] | [References]
[1] BERNARDINO BARCELó . Acute intoxication caused by synthetic cannabinoids 5F-ADB and MMB-2201: A case series[J]. Forensic science international, 2017, 273: Pages e10-e14. DOI: 10.1016/j.forsciint.2017.01.020
[2] F. FRANZ. Structure-metabolism relationships of valine and tert-leucine-derived synthetic cannabinoid receptor agonists: a systematic comparison of the in vitro phase I metabolism using pooled human liver microsomes and high-resolution mass spectrometry[J]. Forensic Toxicology, 2019, 37 1: 316-329. DOI: 10.1007/s11419-018-00462-x |
|
|